Back to Search Start Over

Intraepithelial Sebaceous Gland Carcinoma: A Multicenter Retrospective Case Series.

Authors :
Liu E
Juniat V
Tong JY
Wu A
Tsirbas A
Hersh D
O'Donnell BA
James C
Huilgol SC
Selva D
Source :
Ophthalmic plastic and reconstructive surgery [Ophthalmic Plast Reconstr Surg] 2024 Nov-Dec 01; Vol. 40 (6), pp. 669-676. Date of Electronic Publication: 2024 Apr 29.
Publication Year :
2024

Abstract

Purpose: Intraepithelial sebaceous gland carcinoma is a rare form of sebaceous gland carcinoma, with 10 published case reports to date. The authors report the clinical, histological, and prognostic features of this rare carcinoma.<br />Methods: This is a multicenter retrospective case series of patients from 3 Australian sites. Information collected included patient demographics, clinical risk factors, initial and subsequent presentations, histology results, management, and outcomes.<br />Results: Twelve cases were identified. The average age of presentation was 72 years (range 52-92 years), with more females (n = 8) affected than males. The most common symptoms and signs were ocular irritation (n = 9) and eyelid mass (n = 8), with a predilection toward upper lid involvement. Five cases of sebaceous gland carcinoma were confirmed on initial histology. Initial management included wide local excision with margin control (n = 11), and primary topical mitomycin C (n = 1). Adjunctive conjunctival mapping biopsy was performed in 5 cases. Recurrence occurred in 7 cases, at an average of 31 months (range 7-83 months) after initial treatment. There were no cases of distant metastasis, however, 2 cases developed local invasion. Management of recurrences included exenteration (n = 2), further excisions alone (n = 3), and excision with adjuvant mitomycin C (n = 2).<br />Conclusions: Clinicians and pathologists should have a high index of suspicion for primary intraepithelial sebaceous gland carcinoma on the upper eyelid. Close follow-up is recommended, given the high risk of local recurrence.<br />Competing Interests: The authors have no financial or conflicts of interest to disclose.<br /> (Copyright © 2024 The American Society of Ophthalmic Plastic and Reconstructive Surgery, Inc.)

Details

Language :
English
ISSN :
1537-2677
Volume :
40
Issue :
6
Database :
MEDLINE
Journal :
Ophthalmic plastic and reconstructive surgery
Publication Type :
Academic Journal
Accession number :
39495662
Full Text :
https://doi.org/10.1097/IOP.0000000000002690